The Kellogg Cancer Center strives to provide optimal and comprehensive care to our patients. It is imperative to address both the treatment and prevention of cancer.
It is known that tobacco use is the leading preventable cause of premature death in the United States and causes approximately 435,000 deaths each year. Tobacco use has a causal link to lung, head and neck, pancreatic, bladder, kidney, stomach, uterine, and cervical cancers. There is evidence that continued tobacco use after the diagnosis of cancer decreases survival, reduces treatment efficacy, prolongs/increases treatment toxicity, and increases the risk for recurrence. Despite this evidence, it is reported that 23-35% of head and neck and 13-20% of lung cancer patients continue to smoke after diagnosis.
The Clinical Practice Guidelines for Treating Tobacco Use and Dependence recommend using the time of cancer diagnosis as a “teachable moment” for tobacco cessation. The combination of support from trained professionals and the use of medications significantly increase the likelihood of quitting successfully. Because of this, the Kellogg Cancer Center has developed a Tobacco Cessation Program. Patients will be seen one-on-one by a Tobacco Treatment Specialist, who will help construct a comprehensive plan to help patients quit smoking. This may include counseling on smoking cessation strategies as well as prescription or over-the-counter medication treatment.
If you are interested in the program, please ask your physician for a Tobacco Cessation Counseling Referral or call 847.570.2112 with any questions or for more information.